Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Mar;36(2):127-134.
doi: 10.1016/j.nrl.2020.11.013. Epub 2021 Jan 15.

Encephalopathy and encephalitis during acute SARS-CoV-2 infection. Spanish Society of Neurology COVID-19 Registry

[Article in English, Spanish]
Affiliations
Free article
Observational Study

Encephalopathy and encephalitis during acute SARS-CoV-2 infection. Spanish Society of Neurology COVID-19 Registry

[Article in English, Spanish]
M J Abenza Abildúa et al. Neurologia (Engl Ed). 2021 Mar.
Free article

Abstract

Objectives: Since the beginning of the COVID-19 pandemic, the Spanish Society of Neurology has run a registry of patients with neurological involvement for the purpose of informing clinical neurologists. Encephalopathy and encephalitis were among the most frequently reported complications. In this study, we analyse the characteristics of these complications.

Patients and methods: We conducted a retrospective, descriptive, observational, multicentre study of patients with symptoms compatible with encephalitis or encephalopathy, entered in the Spanish Society of Neurology's COVID-19 Registry from 17 March to 6 June 2020.

Results: A total of 232 patients with neurological symptoms were registered, including 51 cases of encephalopathy or encephalitis (21.9%). None of these patients were healthcare professionals. The most frequent syndromes were mild or moderate confusion (33%) and severe encephalopathy or coma (9.8%). The mean time between onset of infection and onset of neurological symptoms was 8.02 days. Lumbar puncture was performed in 60.8% of patients, with positive PCR results for SARS-CoV-2 in only one case. Brain MRI studies were performed in 47% of patients, with alterations detected in 7.8% of these. EEG studies were performed in 41.3% of cases, detecting alterations in 61.9%.

Conclusions: Encephalopathy and encephalitis are among the complications most frequently reported in the registry. More than one-third of patients presented mild or moderate confusional syndrome. The mean time from onset of infection to onset of neurological symptoms was 8 days (up to 24hours earlier in women than in men). EEG was the most sensitive test in these patients, with very few cases presenting alterations in neuroimaging studies. All patients treated with boluses of corticosteroids or immunoglobulins progressed favourably.

Keywords: COVID-19; Encefalitis; Encefalopatías; Encephalitis; Encephalopathy; Registro SEN; SARS-CoV-2; SARS-CoV2; SEN registry.

PubMed Disclaimer

Similar articles

  • Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry.
    García-Azorín D, Abildúa MJA, Aguirre MEE, Fernández SF, Moncó JCG, Guijarro-Castro C, Platas MG, Delgado FR, Andrés JML, Ezpeleta D; Spanish neuroCOVID registry group. García-Azorín D, et al. J Neurol Sci. 2021 Apr 15;423:117283. doi: 10.1016/j.jns.2020.117283. Epub 2020 Dec 19. J Neurol Sci. 2021. PMID: 33636661 Free PMC article.
  • Neurological complications in critical patients with COVID-19.
    Abenza-Abildúa MJ, Ramírez-Prieto MT, Moreno-Zabaleta R, Arenas-Valls N, Salvador-Maya MA, Algarra-Lucas C, Rojo Moreno-Arrones B, Sánchez-Cordón B, Ojeda-Ruíz de Luna J, Jimeno-Montero C, Navacerrada-Barrero FJ, Borrue-Fernández C, Malmierca-Corral E, Ruíz-Seco P, González-Ruano P, Palmí-Cortés I, Fernández-Travieso J, Mata-Álvarez de Santullano M, Almarcha-Menargues ML, Gutierrez-Gutierrez G, Palacios-Castaño JA, Alonso-Esteban R, Gonzalo-García N, Pérez-López C. Abenza-Abildúa MJ, et al. Neurologia (Engl Ed). 2020 Nov-Dec;35(9):621-627. doi: 10.1016/j.nrl.2020.07.014. Epub 2020 Aug 4. Neurologia (Engl Ed). 2020. PMID: 32912745 Free PMC article.
  • Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
    Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T, Meppiel E. Maury A, et al. Rev Neurol (Paris). 2021 Jan-Feb;177(1-2):51-64. doi: 10.1016/j.neurol.2020.10.001. Epub 2020 Dec 16. Rev Neurol (Paris). 2021. PMID: 33446327 Free PMC article. Review.
  • Neurological Involvements of SARS-CoV2 Infection.
    Gasmi A, Tippairote T, Mujawdiya PK, Gasmi Benahmed A, Menzel A, Dadar M, Bjørklund G. Gasmi A, et al. Mol Neurobiol. 2021 Mar;58(3):944-949. doi: 10.1007/s12035-020-02070-6. Epub 2020 Oct 16. Mol Neurobiol. 2021. PMID: 33064267 Free PMC article. Review.
  • Cytokine release syndrome-associated encephalopathy in patients with COVID-19.
    Perrin P, Collongues N, Baloglu S, Bedo D, Bassand X, Lavaux T, Gautier-Vargas G, Keller N, Kremer S, Fafi-Kremer S, Moulin B, Benotmane I, Caillard S. Perrin P, et al. Eur J Neurol. 2021 Jan;28(1):248-258. doi: 10.1111/ene.14491. Epub 2020 Oct 5. Eur J Neurol. 2021. PMID: 32853434 Free PMC article.

Cited by

Publication types

MeSH terms

Substances